Carregant...
P04.06 PD-L1 Expression is Associated with Wild Type IDH, Immune Response and DNA Damage in Malignant Gliomas
BACKGROUND: Immune-checkpoint inhibition is a promising new approach in glioma therapy. Currently, this therapy is being evaluated for glioblastoma in different clinical trials. Since the molecular mechanism of PD-L1 regulation in gliomas is largely unknown, the present study was initiated.. METHODS...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782582/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.084 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|